Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Optimer, Zogenix, MediciNova, & More 03/01/13 San Diego
Testing New Business Model, Araxes Pharma Signs Deal with Janssen 02/28/13 San Diego
San Diego’s Biotech Leaders of Tomorrow: ‘We Are the Wildcatters’ 02/27/13 San Diego
Zuckerberg Takes a Small Step in Right Direction, Backing Biotech 02/25/13 National
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More 02/21/13 San Diego
NanoString Starts Selling First Breast Cancer Test in EU 02/19/13 Seattle
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
SD Life Sciences Roundup: Sotera, Janssen, Tandem Diabetes, & More 02/08/13 San Diego
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
OncoGenex CFO Resigns After Developing Personal Relationship With CEO 02/04/13 Seattle
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
San Diego Life Sciences Roundup: Isis, Afraxis, Organovo, & More 01/31/13 San Diego
Celsion Liver Cancer Trial Fails to Meet Goals, Stock Plunges 01/31/13 New York
Companion Diagnostics for Cancer Drugs Advancing Personalized Medicine 01/31/13 Boston
Organovo Joins with OHSU to Bio-Engineer Cancer Tissue for Drug R&D 01/30/13 San Diego
Afraxis Licenses its Drug Compounds to Roche Subsidiary Genentech 01/29/13 San Diego
San Diego Life Sciences Roundup: VC Outlook, Organovo, Life, & More 01/28/13 San Diego
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
Progenics Pharmaceuticals Buys Molecular Insight in Stock Swap 01/23/13 Boston
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Sanford-Burnham’s CEO Sees Incredible Opportunity in Move to Roche 01/16/13 San Diego
Roche Recruits Sanford-Burnham CEO John Reed to Head Pharma Research 01/15/13 San Diego
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Page 3 of 49 « previous page · next page »